Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

E.U.R.L PHARMACIE PELAMOURGUES : revenue, balance sheet and financial ratios

E.U.R.L PHARMACIE PELAMOURGUES is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TOULON-SUR-ARROUX (71320), this company of category PME shows in 2024 a net income positive of 15 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - E.U.R.L PHARMACIE PELAMOURGUES (SIREN 508603677)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 15 317 € 49 209 € 51 693 € 86 201 € 124 177 € 111 451 € 71 658 € 83 890 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, E.U.R.L PHARMACIE PELAMOURGUES generates positive net income of 15 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 84 k€ -> 15 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

15 317 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 16%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

16.086%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

67.493%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

77.0%

Solvency indicators evolution
E.U.R.L PHARMACIE PELAMOURGUES

Sector positioning

Debt ratio
16.09 2024
2021
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent

In 2024, the debt ratio of E.U.R.L PHARMACIE PELAMOU... (16.09) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
67.49% 2024
2021
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good

In 2024, the financial autonomy of E.U.R.L PHARMACIE PELAMOU... (67.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 77.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

77.052

Liquidity indicators evolution
E.U.R.L PHARMACIE PELAMOURGUES

Sector positioning

Liquidity ratio
77.05 2024
2021
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch -8 pts over 3 years

In 2024, the liquidity ratio of E.U.R.L PHARMACIE PELAMOU... (77.05) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of E.U.R.L PHARMACIE PELAMOURGUES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of E.U.R.L PHARMACIE PELAMOURGUES is estimated at 213 836 € (range 148 912€ - 319 911€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
148k€ 213k€ 319k€
213 836 € Range: 148 912€ - 319 911€
NAF 5 année 2024

Valuation method used

Net Income Multiple
15 317 € × 14.0x = 213 837 €
Range: 148 912€ - 319 912€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare E.U.R.L PHARMACIE PELAMOURGUES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about E.U.R.L PHARMACIE PELAMOURGUES

What is the revenue of E.U.R.L PHARMACIE PELAMOURGUES ?

The revenue of E.U.R.L PHARMACIE PELAMOURGUES is not publicly disclosed (confidential accounts filed with INPI).

Is E.U.R.L PHARMACIE PELAMOURGUES profitable?

Yes, E.U.R.L PHARMACIE PELAMOURGUES generated a net profit of 15 k€ in 2024.

Where is the headquarters of E.U.R.L PHARMACIE PELAMOURGUES ?

The headquarters of E.U.R.L PHARMACIE PELAMOURGUES is located in TOULON-SUR-ARROUX (71320), in the department Saone-et-Loire.

Where to find the tax return of E.U.R.L PHARMACIE PELAMOURGUES ?

The tax return of E.U.R.L PHARMACIE PELAMOURGUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does E.U.R.L PHARMACIE PELAMOURGUES operate?

E.U.R.L PHARMACIE PELAMOURGUES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.